Tb-1000

Thymosin beta-4 peptide for injury recovery and tissue healing in horses; promotes cellular migration and differentiation. Thymosin beta-4 (Tβ4) synthetic peptide. Mechanism: promotes cellular migration (actin-sequestering protein), angiogenesis, stem cell activation, and anti-inflammatory effects. Stimulates keratinocyte and endothelial cell migration → tissue repair and wound healing; may promote tendon/ligament collagen reorganization. Investigational; subcutaneous or IV administration. Key information Thymosin beta-4 peptide — injectable for tissue repair in horses. Refrigerate lyophilized product. Reconstitute per label. Compounded or research use. Limited regulatory approval.

SQ or IV injection per protocol. Store refrigerated (2–8°C); do not freeze. If a dose is missed This product is given as a single dose or as part of a defined protocol. Contact your veterinarian if a scheduled administration was missed. Contact your veterinarian.

Generally well tolerated with limited veterinary adverse effect data. Injection site reactions (SQ). Rare: hypersensitivity. Long-term safety data limited.

For animals Limited veterinary safety and efficacy data. Administer as directed. {NOT_FOOD} For people handling this medication Wear gloves when handling. Wash hands thoroughly with soap and water after handling. Peptide injectable — Injectable — administered by veterinary staff only. Wash hands thoroughly with soap and water after handling. If accidentally self-injected, seek emergency medical attention immediately. Limited human safety data. Wear gloves.

Contact your veterinarian. Thymosin beta-4 overdose data is limited — contact vet for guidance.